Cancer spread to the brain, Melanoma, Secondary cancers, Skin cancer
Results
Phase 2
The trial was looking at vandetanib and radiotherapy for melanoma that had spread to the brain. It was for people who were unable to have surgery to remove the melanoma in their brain.
Recruitment start: 23 December 2011
Recruitment end: 1 May 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Mark Middleton
Cancer Research UK
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Oxford
This is Cancer Research UK trial number CRUKE/11/017.
Last reviewed: 13 April 2016
CRUK internal database number: 7404
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
